187 related articles for article (PubMed ID: 25765846)
1. Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia.
de Baaij JH; Dorresteijn EM; Hennekam EA; Kamsteeg EJ; Meijer R; Dahan K; Muller M; van den Dorpel MA; Bindels RJ; Hoenderop JG; Devuyst O; Knoers NV
Nephrol Dial Transplant; 2015 Jun; 30(6):952-7. PubMed ID: 25765846
[TBL] [Abstract][Full Text] [Related]
2. Exclusion of mutations in FXYD2, CLDN16 and SLC12A3 in two families with primary renal Mg2+ loss.
Meij IC; van den Heuvel LP; Hemmes S; van der Vliet WA; Willems JL; Monnens LA; Knoers NV
Nephrol Dial Transplant; 2003 Mar; 18(3):512-6. PubMed ID: 12584272
[TBL] [Abstract][Full Text] [Related]
3. A novel CLDN16 mutation in a large family with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis.
Deeb A; Abood SA; Simon J; Dastoor H; Pearce SH; Sayer JA
BMC Res Notes; 2013 Dec; 6():527. PubMed ID: 24321194
[TBL] [Abstract][Full Text] [Related]
4. Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting.
Ferrè S; de Baaij JH; Ferreira P; Germann R; de Klerk JB; Lavrijsen M; van Zeeland F; Venselaar H; Kluijtmans LA; Hoenderop JG; Bindels RJ
J Am Soc Nephrol; 2014 Mar; 25(3):574-86. PubMed ID: 24204001
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular characterization of Turkish patients with familial hypomagnesaemia: novel mutations in TRPM6 and CLDN16 genes.
Guran T; Akcay T; Bereket A; Atay Z; Turan S; Haisch L; Konrad M; Schlingmann KP
Nephrol Dial Transplant; 2012 Feb; 27(2):667-73. PubMed ID: 21669885
[TBL] [Abstract][Full Text] [Related]
6. Retrospective cohort study of familial hypomagnesaemia with hypercalciuria and nephrocalcinosis due to CLDN16 mutations.
Sikora P; Zaniew M; Haisch L; Pulcer B; Szczepańska M; Moczulska A; Rogowska-Kalisz A; Bieniaś B; Tkaczyk M; Ostalska-Nowicka D; Zachwieja K; Hyla-Klekot L; Schlingmann KP; Konrad M
Nephrol Dial Transplant; 2015 Apr; 30(4):636-44. PubMed ID: 25477417
[TBL] [Abstract][Full Text] [Related]
7. Inherited disorders of renal hypomagnesaemia.
Konrad M; Schlingmann KP
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv63-71. PubMed ID: 25165187
[TBL] [Abstract][Full Text] [Related]
8. Human FXYD2 G41R mutation responsible for renal hypomagnesemia behaves as an inward-rectifying cation channel.
Sha Q; Pearson W; Burcea LC; Wigfall DA; Schlesinger PH; Nichols CG; Mercer RW
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F91-9. PubMed ID: 18448590
[TBL] [Abstract][Full Text] [Related]
9. Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit.
Meij IC; Koenderink JB; van Bokhoven H; Assink KF; Groenestege WT; de Pont JJ; Bindels RJ; Monnens LA; van den Heuvel LP; Knoers NV
Nat Genet; 2000 Nov; 26(3):265-6. PubMed ID: 11062458
[TBL] [Abstract][Full Text] [Related]
10. mTOR-Activating Mutations in
Schlingmann KP; Jouret F; Shen K; Nigam A; Arjona FJ; Dafinger C; Houillier P; Jones DP; Kleinerüschkamp F; Oh J; Godefroid N; Eltan M; Güran T; Burtey S; Parotte MC; König J; Braun A; Bos C; Ibars Serra M; Rehmann H; Zwartkruis FJT; Renkema KY; Klingel K; Schulze-Bahr E; Schermer B; Bergmann C; Altmüller J; Thiele H; Beck BB; Dahan K; Sabatini D; Liebau MC; Vargas-Poussou R; Knoers NVAM; Konrad M; de Baaij JHF
J Am Soc Nephrol; 2021 Nov; 32(11):2885-2899. PubMed ID: 34607910
[TBL] [Abstract][Full Text] [Related]
11. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: report of three Turkish siblings.
Peru H; Akin F; Elmas S; Elmaci AM; Konrad M
Pediatr Nephrol; 2008 Jun; 23(6):1009-12. PubMed ID: 18253757
[TBL] [Abstract][Full Text] [Related]
12. Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K+-ATPase gamma-subunit.
Meij IC; Koenderink JB; De Jong JC; De Pont JJ; Monnens LA; Van Den Heuvel LP; Knoers NV
Ann N Y Acad Sci; 2003 Apr; 986():437-43. PubMed ID: 12763862
[TBL] [Abstract][Full Text] [Related]
13. Genetic causes of hypomagnesemia, a clinical overview.
Viering DHHM; de Baaij JHF; Walsh SB; Kleta R; Bockenhauer D
Pediatr Nephrol; 2017 Jul; 32(7):1123-1135. PubMed ID: 27234911
[TBL] [Abstract][Full Text] [Related]
14. Renal Mg handling, FXYD2 and the central role of the Na,K-ATPase.
Mayan H; Farfel Z; Karlish SJD
Physiol Rep; 2018 Sep; 6(17):e13843. PubMed ID: 30175537
[TBL] [Abstract][Full Text] [Related]
15. [Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. Its history].
García-Nieto VM; Claverie-Martín F; Loris-Pablo C
Nefrologia; 2014; 34(1):5-10. PubMed ID: 24463860
[No Abstract] [Full Text] [Related]
16. Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations.
Perdomo-Ramirez A; de Armas-Ortiz M; Ramos-Trujillo E; Suarez-Artiles L; Claverie-Martin F
BMC Med Genet; 2019 Jan; 20(1):6. PubMed ID: 30621608
[TBL] [Abstract][Full Text] [Related]
17. A novel
Zhang H; Ling C; Liu X
Clin Nephrol; 2019 Aug; 92(2):95-97. PubMed ID: 31232269
[TBL] [Abstract][Full Text] [Related]
18. Familial hypomagnesaemia, Hypercalciuria and Nephrocalcinosis associated with a novel mutation of the highly conserved leucine residue 116 of Claudin 16 in a Chinese patient with a delayed diagnosis: a case report.
Lu J; Zhao X; Paiardini A; Lang Y; Bottillo I; Shao L
BMC Nephrol; 2018 Jul; 19(1):181. PubMed ID: 30005619
[TBL] [Abstract][Full Text] [Related]
19. Hypomagnesaemia of hereditary renal origin.
Rodríguez-Soriano J; Vallo A; García-Fuentes M
Pediatr Nephrol; 1987 Jul; 1(3):465-72. PubMed ID: 3153319
[TBL] [Abstract][Full Text] [Related]
20. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: the first four patients in Serbia.
Peco-Antić A; Konrad M; Milosevski-Lomić G; Dimitrijević N
Srp Arh Celok Lek; 2010; 138(5-6):351-5. PubMed ID: 20607983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
